Evquiza intravenous infusion solution 345mg (YJ_code: 2189404A1020, standard: 345mg2.3mL1 bottle), from Ultragenyx Japan, contains Evinacumab (genetical recombination). This monoclonal antibody is approved as an adjunct to other LDL-C-lowering therapies for adults and pediatric patients aged 5 years and older with homozygous familial hypercholesterolemia (HoFH).
Evquiza intravenous infusion solution 345mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).